Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Bertalanffy

Showing results (101-110 of 110) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 110 results.
Cancers|March 25, 2022
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline GlioblastomasPeter Raab, Rouzbeh Banan, Arash Akbarian, et al.
Neurosurgical Review|November 26, 2005
Predictive value of electrocorticography in epilepsy patients with unilateral hippocampal sclerosis undergoing selective amygdalohippocampectomyXu Chen, Ulrich Sure, Anja Haag, et al.
Neurosurgery|October 1, 2010
Epileptogenicity of cavernomas depends on (archi-) cortical localizationKatja Menzler, Xu Chen, Patricia Thiel, et al.
Brain Pathology (Zurich, Switzerland)|May 21, 2008
EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomasMichel Mittelbronn, Patrick Harter, Arne Warth, et al.
Scientific Reports|December 5, 2019
Transcriptome-wide Profiling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signaturesSanthilal Subhash, Norman Kalmbach, Florian Wegner, et al.
Genes & Diseases|August 17, 2023
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation diseaseSouvik Kar, Andrea Perrelli, Kiran Kumar Bali, et al.
Cancer|April 19, 2016
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Silvia Dehler, Elisabeth Jane Rushing, et al.
Human Mutation|February 27, 2008
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complexSonja Stahl, Sabine Gaetzner, Katrin Voss, et al.
Epilepsia|March 10, 2007
Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patientsChristian R Baumann, Nicola Acciarri, Helmut Bertalanffy, et al.
Molecular Medicine (Cambridge, Mass.)|May 7, 2026
Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation diseaseAndrea Perrelli, Ashraqat Ahmed, Anna Onisiforou, et al.
Pageof 11

Showing results (101-110 of 110) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 110 results.
Cancers|March 25, 2022
Differences in the MRI Signature and ADC Values of Diffuse Midline Gliomas with H3 K27M Mutation Compared to Midline GlioblastomasPeter Raab, Rouzbeh Banan, Arash Akbarian, et al.
Neurosurgical Review|November 26, 2005
Predictive value of electrocorticography in epilepsy patients with unilateral hippocampal sclerosis undergoing selective amygdalohippocampectomyXu Chen, Ulrich Sure, Anja Haag, et al.
Neurosurgery|October 1, 2010
Epileptogenicity of cavernomas depends on (archi-) cortical localizationKatja Menzler, Xu Chen, Patricia Thiel, et al.
Brain Pathology (Zurich, Switzerland)|May 21, 2008
EGR-1 is regulated by N-methyl-D-aspartate-receptor stimulation and associated with patient survival in human high grade astrocytomasMichel Mittelbronn, Patrick Harter, Arne Warth, et al.
Scientific Reports|December 5, 2019
Transcriptome-wide Profiling of Cerebral Cavernous Malformations Patients Reveal Important Long noncoding RNA molecular signaturesSanthilal Subhash, Norman Kalmbach, Florian Wegner, et al.
Genes & Diseases|August 17, 2023
Identification of galectin-3 as a novel potential prognostic/predictive biomarker and therapeutic target for cerebral cavernous malformation diseaseSouvik Kar, Andrea Perrelli, Kiran Kumar Bali, et al.
Cancer|April 19, 2016
Glioblastoma in the Canton of Zurich, Switzerland revisited: 2005 to 2009Dorothee Gramatzki, Silvia Dehler, Elisabeth Jane Rushing, et al.
Human Mutation|February 27, 2008
Novel CCM1, CCM2, and CCM3 mutations in patients with cerebral cavernous malformations: in-frame deletion in CCM2 prevents formation of a CCM1/CCM2/CCM3 protein complexSonja Stahl, Sabine Gaetzner, Katrin Voss, et al.
Epilepsia|March 10, 2007
Seizure outcome after resection of supratentorial cavernous malformations: a study of 168 patientsChristian R Baumann, Nicola Acciarri, Helmut Bertalanffy, et al.
Molecular Medicine (Cambridge, Mass.)|May 7, 2026
Identification of the adhesion GPCR ADGRL4/ELTD1 as a novel potential prognostic biomarker for cerebral cavernous malformation diseaseAndrea Perrelli, Ashraqat Ahmed, Anna Onisiforou, et al.
Pageof 11